Citadel Advisors - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$81,589,860
-37.1%
801,000
-37.7%
0.02%
-30.8%
Q2 2023$129,736,052
+1.9%
1,285,661
-7.1%
0.03%
-7.1%
Q1 2023$127,362,408
-44.9%
1,384,374
-45.7%
0.03%
-48.1%
Q4 2022$231,233,033
+50.6%
2,548,865
+26.2%
0.05%
+54.3%
Q3 2022$153,522,000
+19.5%
2,019,773
+32.8%
0.04%
+6.1%
Q2 2022$128,518,000
+25.3%
1,520,395
+30.1%
0.03%
+57.1%
Q1 2022$102,552,000
-33.6%
1,168,690
-33.8%
0.02%
-32.3%
Q4 2021$154,391,000
+77.6%
1,765,078
+66.1%
0.03%
+72.2%
Q3 2021$86,921,000
+9.4%
1,062,862
+22.1%
0.02%0.0%
Q2 2021$79,419,000
+55.0%
870,434
+45.2%
0.02%
+38.5%
Q1 2021$51,237,000
-12.9%
599,398
-3.8%
0.01%
-18.8%
Q4 2020$58,823,000
+128.7%
622,921
+110.6%
0.02%
+100.0%
Q3 2020$25,722,000
-44.2%
295,792
-44.0%
0.01%
-50.0%
Q2 2020$46,107,000
-5.8%
527,900
-11.1%
0.02%
-27.3%
Q1 2020$48,959,000
+94.6%
593,811
+123.5%
0.02%
+100.0%
Q4 2019$25,156,000
-23.7%
265,676
-30.0%
0.01%
-31.2%
Q3 2019$32,986,000
-54.6%
379,589
-52.3%
0.02%
-52.9%
Q2 2019$72,695,000
+118.4%
796,145
+129.9%
0.03%
+112.5%
Q1 2019$33,289,000
-30.1%
346,262
-37.6%
0.02%
-38.5%
Q4 2018$47,626,000
-44.6%
555,013
-44.4%
0.03%
-31.6%
Q3 2018$85,931,000
+617.6%
997,347
+529.2%
0.04%
+533.3%
Q2 2018$11,974,000
-43.7%
158,516
-39.7%
0.01%
-50.0%
Q1 2018$21,265,000
-32.2%
263,016
-29.6%
0.01%
-36.8%
Q4 2017$31,386,000
+213.3%
373,820
+220.3%
0.02%
+137.5%
Q3 2017$10,018,000
+1.1%
116,700
-1.7%
0.01%
-11.1%
Q2 2017$9,911,000
-56.2%
118,737
-61.0%
0.01%
-55.0%
Q1 2017$22,635,000
-4.2%
304,761
-6.0%
0.02%
-16.7%
Q4 2016$23,623,000
+299.2%
324,317
+332.7%
0.02%
+380.0%
Q3 2016$5,918,000
+156.6%
74,944
+168.2%
0.01%
+66.7%
Q2 2016$2,306,000
-80.9%
27,948
-83.2%
0.00%
-80.0%
Q1 2016$12,078,000
+51.8%
166,734
+80.4%
0.02%
+66.7%
Q4 2015$7,954,000
-32.8%
92,441
-28.2%
0.01%
-18.2%
Q3 2015$11,834,000
+1671.6%
128,743
+1794.4%
0.01%
+1000.0%
Q2 2015$668,000
-90.9%
6,796
-90.9%
0.00%
-85.7%
Q1 2015$7,329,000
+2536.3%
74,325
+2377.5%
0.01%
Q4 2014$278,000
-1.4%
3,0000.0%0.00%
Q3 2014$282,000
-57.5%
3,000
-59.1%
0.00%
-100.0%
Q2 2014$664,000
-7.4%
7,338
-13.0%
0.00%0.0%
Q1 2014$717,000
-64.6%
8,438
-66.5%
0.00%
-66.7%
Q4 2013$2,025,000
+780.4%
25,188
+739.6%
0.00%
Q3 2013$230,0003,0000.00%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders